Company Filing History:
Years Active: 2021
Title: Giovanni Bellesia: Innovator in Nanopore Technology
Introduction
Giovanni Bellesia is a prominent inventor based in San Jose, CA, known for his contributions to the field of DNA sequencing technology. His innovative work has led to the development of nanopore protein conjugates, which have significant implications for genetic research and diagnostics.
Latest Patents
Bellesia holds a patent for "Nanopore protein conjugates and uses thereof." This patent describes nanopore protein conjugates that can be utilized in DNA sequencing reactions. The conjugates consist of a nanopore protein monomer that is linked to a DNA binding domain. The nanopore protein monomer is designed to oligomerize with other monomers, while the DNA binding domain effectively binds to a template DNA strand. Notably, the nanopore protein monomer can be an alpha-hemolysin monomer or a variant, and the DNA binding domain may include an Sso7d protein or its variants. The patent also details nanopore protein assemblies that incorporate these conjugates, along with methods for using them in sequencing reactions.
Career Highlights
Throughout his career, Giovanni Bellesia has worked with leading companies in the biotechnology sector. He has been associated with Roche Sequencing Solutions, Inc. and Genia Technologies, Inc., where he has contributed to advancements in sequencing technologies and related applications.
Collaborations
Bellesia has collaborated with notable professionals in his field, including Timothy Kellogg Craig and Corissa Harris. These collaborations have further enhanced his research and development efforts in nanopore technology.
Conclusion
Giovanni Bellesia's innovative work in nanopore protein conjugates represents a significant advancement in DNA sequencing technology. His contributions continue to influence the field and pave the way for future developments in genetic research.